MAI Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
MAI Capital Management's EW Position: Q2 2026 in Review
MAI Capital Management reduced its Edwards Lifesciences (EW) stake by 70% in Q2 2026, selling an estimated $5.22M and leaving 26,116 shares worth $2.36M. The position accounts for 0.01% of the portfolio, ranked #654.
MAI Capital Management first reported a position in EW in Q1 2019 and has held it in 29 quarters since. The position peaked at $7.5M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- MAI Capital Management held 26,116 shares of Edwards Lifesciences worth $2.36M as of Q2 2026.
- MAI Capital Management sold 62,364 Edwards Lifesciences shares in Q2 2026, an estimated $5.22M.
- Edwards Lifesciences made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #654 holding.
- MAI Capital Management first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 29 quarters since.
- MAI Capital Management's Edwards Lifesciences position peaked at $7.5M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.